# AptarGroup to acquire 80% of Weihai Hengyu Medical Products

AptarGroup entered into an agreement to acquire 80% of the equity interests of Weihai Hengyu Medical Products, a Chinese manufacturer of elastomeric and plastic components for injectable drug delivery. The acquisition adds local manufacturing capacity in China.

- Type: Acquisition
- Announced: 2021-07-28
- Where: Weihai, China, China
- Status: announced
- Products: elastomeric components, plastic components, injectable drug delivery components
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [AptarGroup](https://endata.com/companies/3654.md) (acquirer)
- [Weihai Hengyu Medical Products](https://endata.com/companies/56738.md) (target)

## Sources

- [investors.aptar.com](https://investors.aptar.com/news/news-details/2021/Aptar-Enters-into-Agreement-with-Weihai-Hengyu-Medical-Products-to-Add-Elastomeric-and-Plastic-Component-Manufacturing-Capabilities-in-China-for-Injectable-Drug-Delivery/default.aspx), 2021-07-28: "This majority equity investment is a strategic step that strengthens our competitive position in Asia and in the high-growth injectable drug delivery market."
- [plasticsnews.com](https://www.plasticsnews.com/news/acquisition-gives-aptar-rubber-plastic-medical-molding-china/), 2021-08-02: "Aptar will acquire 80 percent of the equity interests of Weihai Hengyu Medical Products Co. Ltd., a leading Chinese manufacturer of elastomeric and plastic components used in injectable drug delivery."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.